– Building a strong and sustainable Life science sector – together


Company representatives from the prosperous Life science industry, will share their journey, success strategies and examples concerning entrepreneurship. Business leaders, researchers, marketers, economists, business developers and other experts jointly describe the environment their companies operate in, what drives them and what challenges they face.
Listen, be inspired, learn and take the insights to your company and gain value today!

New episodes will be published every second week from May 2021. In addition, to give you even more insight in the everyday life of the entrepreneurs, our LinkedIn account will be ”hijacked” by the company presented, during the week of promotion. Stay up to date by following STUNS Life science on LinkedIn.

This podcast is sponsored through the project BIO-X Accelerate led by STUNS Life science with the goal of promoting a sustainable growth of the Life science industry in East Middle Sweden. The project is funded by European Regional Development Fund (ERDF), Region Uppsala and STUNS Life Science.

We look forward to sharing value with you. 

Podcast series

Celluminova AB

Near-instant detection of live stem cells

– The Biomarker Gliostem® will help neurosurgeons distinguish between healthy and cancerous tissue during brain tumor surgery

Celluminova specializes in developing new tools for stem cell research, including cancer stem cells. The patented biomarker GlioStem is intended for the detection and visualization of stem cell-like cells in brain tumors. Today, there are no products on the market that target stem cell-like cells in these tumors. The goal for GlioStem is to be used during surgery to completely remove tumor tissue and thereby lead to increased patient survival and quality of life.

Read more about Celluminova

Coming next


Week 19

Gradientech AB
– Precision medicine for a sustainable world

Guests: Sara Thorslund, CEO and Teresa Fernandez Zafra, Product manager


Week 21

PU Sensor AB
– Improved risk assessment to reduce the occurrence of pressure ulcers

Guest: Johannes Walfridsson, CEO


Week 23

Ilya Pharma AB
-Developing off-the-shelf immunotherapies to treat wounds in skin and mucosa

Guests: Evelina Vågesjö, CEO, Mia Phillipson Co-Founder and Stefan Roos, Co-Founder


New podcasts are to be published regularly. Due to the prevailing circumstances with covid pandemic, and the recommendations from authorities, the recordings will be paused until further notice. Follow us on LinkedIn to stay up to date.
Picture: Logo of the European Regional Development Fund